In:
Arthritis und Rheuma, Georg Thieme Verlag KG, Vol. 40, No. 04 ( 2020-08), p. 260-269
Abstract:
The therapy of juvenile idiopathic arthritis (JIA) has undergone significant changes during the past two decades also due to the availability of new biologic substances. Therapy guidelines gathering the available evidence are crucial for clinical decision-making. The current interdisciplinary therapy guideline was updated between 2018 and 2019 in different steps, leading to an updated adoption of recommendations and principles of medical and non-medical therapy of JIA. The main focus and goal of all therapeutical considerations remains a rapid control of inflammation leading to and maintaining remission while avoiding disease or therapy-associated damage. This shall furthermore allow an appropriate somatic and psycho-social development along with an adequate health-related quality of life and participation of children and adolescents with JIA.
Type of Medium:
Online Resource
ISSN:
0176-5167
,
2567-5753
Language:
German
Publisher:
Georg Thieme Verlag KG
Publication Date:
2020
Permalink